Comparison of brainwave indices in overactive children receiving automoxetine and ritalin

Comparison of QEEG(Quantitaive electroencephalography) indices in children with ADHD (Attention deficit hyperactivity disorder)in two groups receiving automoxetine and ritalin

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20140825018927N7

Enrollment

Registered

2019-12-02

Start date

2019-12-10

Completion date

Unknown

Last updated

2019-12-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

??? ????? - ??? ????. Attention-deficit hyperactivity disorders

Interventions

Intervention 1: Children with ADHD, aged 7-12 years, enter the study after obtaining informed consent from parental clinical trial studies and having inclusion and exclusion criteria. Parents' Connors

Eligibility

Sex/Gender

Male

Age

7 Years to 12 Years

Inclusion criteria

Inclusion criteria: 7-12 years old Male gender Parental consent for child participation in research IQ greater than 70 Diagnosis of ADHD by a child and adolescent psychiatrist

Exclusion criteria

Exclusion criteria: History of medication for ADHD Other psychiatric disorders Existence of medical diseases

Design outcomes

Primary

Measure	Time frame
Brainwave indices. Timepoint: At baseline, 3 months later. Method of measurement: Quantitative electroencephalography ( Qualitative brainwave recorder,LORETA).	—

Countries

Iran (Islamic Republic of)

Contacts

Public Contactsahar salimi

Tabriz University of Medical Sciences

sahar65salimi@yahoo.com+98 41 3383 1269

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026